Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins

Successful vaccine efforts countering the COVID-19 pandemic are centralized around the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein as viral antigen and have greatly reduced the morbidity and mortality associated with COVID-19. Since the start of this pandemic, SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Donnell, Kyle L., Gourdine, Tylisha, Fletcher, Paige, Clancy, Chad S., Marzi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638159/
https://www.ncbi.nlm.nih.gov/pubmed/36353642
http://dx.doi.org/10.3389/fimmu.2022.1025500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638159/
https://www.ncbi.nlm.nih.gov/pubmed/36353642
http://dx.doi.org/10.3389/fimmu.2022.1025500

Ejemplares similares